Analyst ratings and price targets can significantly influence investor sentiment and stock price. The reiteration of a 'Buy' rating and a $10 price target by HC Wainwright & Co. indicates their positive outlook on Reviva Pharmaceuticals, which could lead to increased investor interest and a potential rise in the stock's price in the short term.